The NGB unique expression in cancer tissue, relative to the normal counterpart, its anti-apoptotic role [8], and its involvement in breast cancer insensitivity to chemotherapeutic agents (e.g., paclitaxel) [15], introduces new insights in breast cancer research, supporting the possible role of NGB as a new biomarker of breast malignant transformation and as a target for clinical interventions. Here, NGB is linked to breast cancer.